
AHA: coffee drinkers with treated AFib were 39% less likely to have a recurrence
The American Heart Association summarizes the DECAF trial: adults treated for AFib who drank at least one cup of coffee daily for 6 months had 39% fewer recurrences than those who abstained. The 200-person trial was published in JAMA, though some people still find caffeine triggers AFib symptoms.
